跳至主要内容
临床试验/NCT04828525
NCT04828525Unknown3 期

Corticosteroids as an Additional Treatment for Mastoiditis In Children

ori snapiri0 个研究点目标入组 50 人开始时间: 2021年4月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
发起方
入组人数
50
主要终点
Time from the beginning of the treatment until clinical and laboratory findings are within normal limits

研究概览

简要总结

The aim of the study is to assess the influence of adjuvant corticosteroid treatment in acute mastoiditis in children. we expect a better outcome in children treated with both corticosteroids and antibiotics including lower rates in complications and earlier decline in fever and inflammatory markers.

详细描述

The research is a multi-centered, prospective, placebo-control, randomized controlled trial. The study group will be comprised of children diagnosed with acute mastoiditis and hospitalized in a pediatric medical center.

The participating patients will be randomized divided into two groups. Research group will be given dexamethasone treatment (course of 16 doses, 0.15 mg/kg/dose every 6 hours) in addition to antibiotic treatment. Control group will be given 16 doses of 0.9% normal saline in addition to antibiotic treatment. Management and treatment will be conducted according to clinical condition and laboratory findings as for routine institution protocols. It should be noted that the regular institutional management of children enrolled for the study will not be changed due to our research.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

盲法说明

participants will be randomized divided into two groups. each group will be given dexamethasone or 0.9% normal saline. only the pharmacist will not be masked to the procedure.

入排标准

年龄范围
6 Months 至 12 Years(Child)
性别
All
接受健康志愿者

入选标准

  • acute mastoiditis

排除标准

  • immunodeficiency (congenital or acquired)
  • significant chronic disease
  • hypertension
  • recurrent mastoiditis

研究组 & 干预措施

Placebo

Placebo Comparator

participants will be given normal saline in addition to conventional treatment

干预措施: normal saline (Drug)

Experimental

Experimental

participants will be given corticosteroids in addition to conventional treatment

干预措施: Dexamethasone (Drug)

结局指标

主要结局

Time from the beginning of the treatment until clinical and laboratory findings are within normal limits

时间窗: during hospitalization, anticipated 1-2 weeks

fever, crp levels

次要结局

  • Complication rates(during hospitalization, anticipated 1-2 weeks)

研究者

发起方
ori snapiri
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

ori snapiri

Pediatrician, Principal Investigator, Clinical doctor

Rabin Medical Center

相似试验

Corticosteroids as an Additional Treatment for... | 临床试验